Skip to content

Sunday, June 4, 2023

Latest:

Sargassum seaweed carries potential for respiratory problems
FROM THE LABS: Gene Tiam1 orchestrates the development of chronic neuropathic pain
Addressing hunger on the ground in Colombia
Is there hidden meaning in “madness”?
Changes in gene p16 create a permissive microenvironment for colon cancer growth

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

ER+ breast cancer

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

May 16, 2023May 16, 2023endocrine therapy-resistant breast cancer, ER+ breast cancer, estrogen receptor 1, fusion genes, pralsetinib, Research, RET kinase

The findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.

Immune checkpoint therapy for ER+ breast cancers, a missed opportunity?

December 5, 2019December 5, 2019endocrine treatment resistant breast cancer, ER+ breast cancer, immune check points, luminal A breast cancer, luminal B breast cancer, Research

In the United States, apart from some forms of skin cancer, breast cancer is the most common cancer in women. It is also the most

From the Labs Image of the Month

From the Labs: The Liver’s biliary tree

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951